VC-backed EndoStim pulls IPO

According to an SEC filing, St.Louis, Missouri and Netherlands-based EndoStim, which focuses on treating acid reflux, has withdrawn its planned IPO. The reason given was "market conditions." Its backers include Santé Ventures, Prolog Ventures and Vectis Healthcare & Life Sciences Fund.

North AmericaUSBriefs